| abstract |
(57) [Summary] The present invention relates to a recombinant vector comprising a polynucleotide containing a central initiation cis-type active region (cPPT) and a termination cis-type active region (CTS), wherein the vector comprises: It further includes a predicted nucleotide sequence (transgene or nucleotide sequence of interest), and retranscriptional regulatory, expression and packaging signals of retrovirus or retrovirus-like origin. |